Related Experiment Video
Updated: Aug 8, 2026
Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue
Published on: January 6, 2012
Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with
K E Cox1, M Piva, K L Sharpe-Timms
1Department of Obstetrics and Gynecology, University of Missouri, Columbia, Missouri 65212, USA.
Abstract:
In vivo levels of mRNA and the specificity of the extrauterine environment on matrix metalloproteinase (MMP)-3, MMP-2, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 were evaluated in eutopic and ectopic endometrial tissue during the establishment of endometriosis in a rat model. Uteri and endometriotic implants were collected and frozen at 36 h, 2 wk, and 4 wk postsurgery to study in vivo mRNA levels. Intact uteri, uterine tissues implanted in the peritoneum or under the skin, and peritoneal adipose implants were collected at 2 wk, halved, and either frozen or cultured. Gene-specific reverse transcriptase-polymerase chain reaction was performed to detect and quantify MMP-2, MMP-3, and TIMP-1 mRNA levels. The peritoneal endometriotic implants progressed from avascularized implants, to vascularized red lesions, to well-established encapsulated cysts. In vivo, MMP-3 mRNA was detectable at all times in ectopic tissues but not in eutopic uterine tissues, whereas MMP-2 and TIMP-1 were ubiquitously expressed at all times in both tissues. In vitro, only MMP-3 mRNA levels were elevated in endometrial tissues collected from the intact uterine and from under the skin, at levels similar to in vivo endometriotic implant MMP-3. In conclusion, ectopic endometrial MMP-3 may participate in the process of invasion and tissue remodeling that is hypothesized to occur in the pathogenesis of endometriosis.
Insights
Matrix metalloproteinase (MMP)-3 mRNA is present in ectopic endometrial tissue but not in eutopic uterine tissue during endometriosis development. This suggests MMP-3 plays a role in endometriosis pathogenesis and tissue remodeling.
Area of Science:
- Reproductive biology
- Molecular biology
- Pathogenesis of endometriosis
Background:
- Endometriosis is a complex gynecological condition characterized by the presence of endometrial tissue outside the uterus.
- The molecular mechanisms underlying endometriosis establishment and progression, particularly the role of specific enzymes, are not fully understood.
Purpose of the Study:
- To investigate the in vivo and in vitro expression of matrix metalloproteinase (MMP)-3, MMP-2, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 in a rat model of endometriosis.
- To determine the influence of the extrauterine environment on the expression of these key matrix remodeling factors.
Main Methods:
- A rat model was used to establish endometriosis, with tissues collected at various time points post-surgery (36 h, 2 wk, 4 wk).
- Reverse transcriptase-polymerase chain reaction (RT-PCR) was employed to quantify mRNA levels of MMP-3, MMP-2, and TIMP-1 in both eutopic (uterine) and ectopic (implant) endometrial tissues.
- Tissues were analyzed both in vivo (frozen) and in vitro (cultured) to assess gene expression under different conditions.
Main Results:
- MMP-3 mRNA was detected in ectopic endometrial implants throughout the study period but was absent in eutopic uterine tissue.
- MMP-2 and TIMP-1 mRNA were ubiquitously expressed in both eutopic and ectopic tissues at all measured time points.
- In vitro experiments showed elevated MMP-3 mRNA levels in uterine tissues cultured under conditions mimicking the ectopic environment.
Conclusions:
- Ectopic endometrial MMP-3 expression appears to be specific to the extrauterine environment and may be crucial for the invasion and tissue remodeling processes involved in endometriosis pathogenesis.
- These findings highlight MMP-3 as a potential therapeutic target for managing endometriosis.
